These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11358679)

  • 61. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
    Averna M; Zaninelli A; Le Grazie C; Gensini GF
    J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of simvastatin and ezetimibe in lowering low-density lipoprotein cholesterol in subjects with type 1 and type 2 diabetes mellitus.
    Ciriacks K; Coly G; Krishnaswami S; Patel SB; Kidambi S
    Metab Syndr Relat Disord; 2015 Mar; 13(2):84-90. PubMed ID: 25490061
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus.
    Noutsou M; Georgopoulos A
    J Diabetes Complications; 1999; 13(2):98-104. PubMed ID: 10432174
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus.
    Constance C; Westphal S; Chung N; Lund M; McCrary Sisk C; Johnson-Levonas AO; Massaad R; Allen C
    Diabetes Obes Metab; 2007 Jul; 9(4):575-84. PubMed ID: 17451425
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
    BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stiffening of connective tissue in elderly diabetic patients: relevance to diabetic nephropathy and oxidative stress.
    Aoki Y; Yazaki K; Shirotori K; Yanagisawa Y; Oguchi H; Kiyosawa K; Furuta S
    Diabetologia; 1993 Jan; 36(1):79-83. PubMed ID: 8436258
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study.
    Gallego PH; Craig ME; Hing S; Donaghue KC
    BMJ; 2008 Aug; 337():a918. PubMed ID: 18728082
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy?
    Strojek K; Grzeszczak W; Górska J; Leschinger MI; Ritz E
    J Am Soc Nephrol; 2001 Mar; 12(3):602-605. PubMed ID: 11181810
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes.
    Jialal I; Miguelino E; Griffen SC; Devaraj S
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3136-40. PubMed ID: 17519305
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Forearm arterial vascular responsiveness in insulin-dependent diabetic subjects.
    Steel M; Nolan C; Nankervis A; Kiers L; Kilpatrick C; Lichtenstein M; O'Dea K; Larkins R
    Diabetes Res Clin Pract; 1993; 21(2-3):127-36. PubMed ID: 8269813
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of simvastatin in children with hyperlipidemia secondary to kidney disorders.
    García-de-la-Puente S; Arredondo-García JL; Gutiérrez-Castrellón P; Bojorquez-Ochoa A; Maya ER; Pérez-Martínez Mdel P
    Pediatr Nephrol; 2009 Jun; 24(6):1205-10. PubMed ID: 19238452
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].
    Heart Protection Study Collaborative Group
    BMC Med; 2005 Mar; 3():6. PubMed ID: 15771782
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
    Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
    Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes Control and Complications Trial Research Group
    Diabetes Care; 2000 Aug; 23(8):1084-91. PubMed ID: 10937502
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial.
    Kramer CK; Retnakaran R
    Diabet Med; 2013 Nov; 30(11):1333-41. PubMed ID: 23909911
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incidence of microvascular complications in type 1 diabetic subjects with limited joint mobility: a 10-year prospective study.
    McCance DR; Crowe G; Quinn MJ; Smye M; Kennedy L
    Diabet Med; 1993 Nov; 10(9):807-10. PubMed ID: 8281723
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diabetes microvascular complications in prepubertal children.
    Donaghue KC; Fairchild JM; Chan A; Hing SJ; King J; Howard NJ; Silink M
    J Pediatr Endocrinol Metab; 1997; 10(6):579-85. PubMed ID: 9467127
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adiponectin is inversely associated with renal function in type 1 diabetic patients.
    Schalkwijk CG; Chaturvedi N; Schram MT; Fuller JH; Stehouwer CD;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):129-35. PubMed ID: 16219717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.